Taylor Simon
Psychiatric/Mental Health · Amherst, NYNPI 1972386746
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 195 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 16.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,774, more than ten times the $96 reported in 2023. Among psychiatric/mental health clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 195 payments — averaging $23.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$728
- Lundbeck LLC$512
- Neurocrine Biosciences, Inc.$482
- AbbVie$370
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$308
- Alkermes, Inc.$303
- plus $2K from 18 others
What the payments were for
- Food & beverage$4,563100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 27 | $728 |
| Lundbeck LLC | 30 | $512 |
| Neurocrine Biosciences, Inc. | 17 | $482 |
| AbbVie | 15 | $370 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 12 | $308 |
| Alkermes, Inc. | 16 | $303 |
| Johnson & Johnson | 8 | $296 |
| Vanda Pharmaceuticals Inc. | 10 | $262 |
| Corium, LLC | 8 | $182 |
| E.r. Squibb & Sons, L.L.C. | 3 | $164 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $157 |
| Idorsia Pharmaceuticals US Inc | 9 | $145 |
| Teva Pharmaceuticals USA, Inc. | 6 | $143 |
| Collegium Pharmaceutical, Inc. | 6 | $125 |
| Axsome Therapeutics, Inc. | 5 | $122 |
| Bausch Health US, LLC | 2 | $46 |
| Almatica Pharma LLC | 3 | $42 |
| Supernus Pharmaceuticals, Inc. | 2 | $41 |
| Livanova USA, Inc. | 2 | $38 |
| Biogen | 1 | $29 |
| Novo Nordisk | 1 | $20 |
| Neos Therapeutics, LP | 1 | $17 |
| Noven Therapeutics, LLC | 1 | $16 |
| Luye Pharma (USA) Ltd. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,563 in reported general payments places this provider in the 90th percentile of 2,385 psychiatric/mental health providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Duloxetine Hcl | 12 | $385 |
| Bupropion XlBupropion Hcl | 14 | $272 |
| Clonazepam | 21 | $174 |
| Trazodone Hcl | 11 | $173 |
| Alprazolam | 18 | $123 |
| Buspirone Hcl | 11 | $78 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Amherst
- Jeanne Salada-ConroyAmherst$10K
- Tammy RussoNiskayuna$568K
- Carrie EdickSchenectady$484K
- Eric SpronzCentereach$448K
- Terry Jo Brooks-DevlinTonawanda$176K
- Kevin SiewersStaten Island$155K
- Daniel BreeyearNiskayuna$149K
- Elijah StevensBinghamton$131K
- Kayanna JonasFar Rockaway$93K
- Alexis CrisafiFishkill$70K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.